HSA
DTIL icon

HBK Sorce Advisory’s Precision BioSciences DTIL Stock Holding History

HBK Sorce Advisory’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.9K Hold
10,164
– – ﹤0.01% 645
2026
Q1 		$78.2K Buy
10,164
+130
+1% +$600 ﹤0.01% 632
2025
Q4 		$38.1K Buy
+10,034
New +$57K ﹤0.01% 615
2024
Q1 		– Sell
-450
Closed -$4.93K – 612
2023
Q4 		$4.93K Hold
450
– – ﹤0.01% 567
2023
Q3 		$4.61K Buy
+450
New +$6.92K ﹤0.01% 563

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

HBK Sorce Advisory's DTIL Position: Q2 2026 in Review

HBK Sorce Advisory held its Precision BioSciences (DTIL) position steady in Q2 2026 at 10,164 shares worth $75.9K. The position accounts for ﹤0.01% of the portfolio, ranked #645.

HBK Sorce Advisory first reported a position in DTIL in Q3 2023 and has held it in 5 quarters since. The position peaked at $78.2K in Q1 2026. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • HBK Sorce Advisory held 10,164 shares of Precision BioSciences worth $75.9K as of Q2 2026.
  • HBK Sorce Advisory left its Precision BioSciences share count unchanged in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of HBK Sorce Advisory's portfolio in Q2 2026, its #645 holding.
  • HBK Sorce Advisory first reported a position in Precision BioSciences in Q3 2023 and has held it in 5 quarters since.
  • HBK Sorce Advisory's Precision BioSciences position peaked at $78.2K in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on HBK Sorce Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.